Bio-Rad Laboratories (BIO)

May 29, 2025, 4:30 PM EDT - 5 days ago

Bio-Rad's Management to Host Investor Meetings During Jefferies Global Healthcare Conference

May 12, 2025, 4:30 PM EDT - 22 days ago

Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare Conference

May 1, 2025, 10:35 PM EDT - 4 weeks ago

Bio-Rad Laboratories, Inc. (BIO) Q1 2025 Earnings Call Transcript

May 1, 2025, 4:15 PM EDT - 4 weeks ago

Bio-Rad Reports First-Quarter 2025 Financial Results

Feb 13, 2025, 11:45 PM EST - 3 months ago

Bio-Rad Laboratories, Inc. (BIO) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 4:20 PM EST - 3 months ago

Bio-Rad Reports Fourth-Quarter and Full-Year 2024 Financial Results

Feb 13, 2025, 4:15 PM EST - 3 months ago

Bio-Rad Offers to Acquire Digital PCR Developer Stilla Technologies

Jan 27, 2025, 5:00 PM EST - 4 months ago

Bio-Rad to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025

Jan 8, 2025, 8:15 AM EST - 5 months ago

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests

LH

Jan 2, 2025, 4:30 PM EST - 5 months ago

Bio-Rad's Management to Host Investor Meetings at J.P. Morgan's 43rd Annual Healthcare Conference

Nov 21, 2024, 9:00 AM EST - 6 months ago

Bio-Rad's Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference

Oct 31, 2024, 9:00 AM EDT - 7 months ago

Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference

Oct 30, 2024, 8:22 PM EDT - 7 months ago

Bio-Rad Laboratories, Inc. (BIO) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 6:09 PM EDT - 7 months ago

Bio-Rad Laboratories beats quarterly profit estimates on strong sales in diagnostics unit

Oct 30, 2024, 4:15 PM EDT - 7 months ago

Bio-Rad Reports Third-Quarter 2024 Financial Results

Oct 14, 2024, 5:30 PM EDT - 8 months ago

Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024

Sep 6, 2024, 6:43 PM EDT - 9 months ago

Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

ADNT CHCT CMP CNH DBI DDD DELL

Aug 22, 2024, 4:30 PM EDT - 10 months ago

Bio-Rad's Management to Participate in Fireside Chat During Wells Fargo's 2024 Healthcare Conference

Aug 20, 2024, 8:30 AM EDT - 10 months ago

Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer

Aug 1, 2024, 10:47 PM EDT - 10 months ago

Bio-Rad Laboratories, Inc. (BIO) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 5:56 PM EDT - 10 months ago

Bio-Rad Labs cuts annual revenue forecast on weak demand for diagnostics products

Aug 1, 2024, 4:15 PM EDT - 10 months ago

Bio-Rad Reports Second-Quarter 2024 Financial Results

Jul 17, 2024, 4:30 PM EDT - 11 months ago

Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024

May 30, 2024, 9:00 AM EDT - 1 year ago

Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group

May 23, 2024, 4:15 PM EDT - 1 year ago

Bio-Rad's Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference

May 7, 2024, 11:16 PM EDT - 1 year ago

Bio-Rad Laboratories, Inc. (BIO) Q1 2024 Earnings Call Transcript

May 7, 2024, 6:11 PM EDT - 1 year ago

Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip

May 7, 2024, 4:15 PM EDT - 1 year ago

Bio-Rad Reports First-Quarter 2024 Financial Results

May 1, 2024, 9:00 AM EDT - 1 year ago

Bio-Rad's Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference

Apr 26, 2024, 8:30 AM EDT - 1 year ago

Bio-Rad Announces Life Science Group Management Changes

Apr 18, 2024, 9:00 AM EDT - 1 year ago

Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024

Apr 10, 2024, 4:15 PM EDT - 1 year ago

Bio-Rad's Chief Operating Officer Andrew Last to Retire

Mar 20, 2024, 8:30 AM EDT - 1 year ago

Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer

Feb 22, 2024, 4:30 PM EST - 1 year ago

Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day

Feb 15, 2024, 6:54 PM EST - 1 year ago

Bio-Rad Laboratories, Inc. (BIO) Q4 2023 Earnings Call Transcript

Feb 15, 2024, 6:51 PM EST - 1 year ago

Bio Rad Labs rises after posting upbeat fourth-quarter profit

Feb 15, 2024, 4:15 PM EST - 1 year ago

Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results

Jan 24, 2024, 5:00 PM EST - 1 year ago

Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024

Jan 2, 2024, 4:15 PM EST - 1 year ago

Bio-Rad's Management to Host Investor Meetings at J.P. Morgan's 42nd Annual Healthcare Conference

Dec 26, 2023, 11:29 AM EST - 1 year ago

S&P 500 Stocks With the Most Upside

APA APTV FSLR GM HAL LVS MRNA

Dec 20, 2023, 3:07 PM EST - 1 year ago

6 Stock Picks in Healthcare for 2024

BMY CI HUM INCY MRNA

Oct 26, 2023, 8:04 PM EDT - 1 year ago

Bio-Rad Laboratories, Inc. (BIO) Q3 2023 Earnings Call Transcript

Oct 26, 2023, 5:46 PM EDT - 1 year ago

Bio-Rad Labs cuts 2023 revenue growth forecast as biotechs cut spending

Oct 26, 2023, 4:15 PM EDT - 1 year ago

Bio-Rad Reports Third-Quarter 2023 Financial Results

Oct 5, 2023, 8:30 AM EDT - 1 year ago

Bio-Rad to Report Third Quarter 2023 Financial Results on Thursday, October 26, 2023

Aug 28, 2023, 4:15 PM EDT - 1 year ago

Bio-Rad to Participate in Fireside Chat During Wells Fargo's 2023 Healthcare Conference

Aug 10, 2023, 7:03 AM EDT - 1 year ago

Bio-Rad: A Cash Flow Returns On Investments Analysis

Aug 3, 2023, 11:33 PM EDT - 1 year ago

Bio-Rad Laboratories, Inc. (BIO) Q2 2023 Earnings Call Transcript

Aug 3, 2023, 4:15 PM EDT - 1 year ago

Bio-Rad Reports Second-Quarter 2023 Financial Results

Jul 26, 2023, 4:15 PM EDT - 2 years ago

Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement

QGEN